Article Text
Commentary
Body fatness and bevacizumab-based therapy in metastatic colorectal cancer
Statistics from Altmetric.com
Footnotes
Linked articles 188946
Funding The author is a ‘New Blood’ HEFCE senior lecturer.
Competing interest None.
Provenance and peer review Commissioned; not externally peer reviewed.